<DOC>
	<DOCNO>NCT00456794</DOCNO>
	<brief_summary>A 12-week , multicenter , double-blind , randomize study design evaluate safety efficacy 20 60 mg/day istradefylline compare placebo subject OFF-time phenomenon advance Parkinson 's disease treat levodopa/carbidopa .</brief_summary>
	<brief_title>12-Week , Double-Blind , Placebo-Controlled Study 20 60 mg/Day Istradefylline Parkinson 's Disease Patients Levodopa/Carbodopa</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Istradefylline</mesh_term>
	<mesh_term>Levodopa</mesh_term>
	<criteria>1 . United Kingdom Parkinson 's Disease Society brain bank diagnostic criterion ( Steps 1 2 ) . 2 . Modified Hoehn Yahr OFF state IIIV . 3 . Treated levodopa/carbidopa least one year stable regimen 4 week prior randomization . 4 . Taking least 4 dos levodopa/carbidopa per day ( 3 dos least 2 dos contain slowrelease formulation ) predictable end dose wear . 5 . Successfully compete Parkinson 's disease patient diary training least 120 minute OFF time per day . 6 . Stable regimen antiparkinson 's medication 4 week prior randomization . 7 . At least 30 year age able give write informed consent . 1 . Treatment liquid levodopa/carbidopa within 4 week randomization . 2 . Treatment MAO inhibitor except selegiline . 3 . Treatment within 3 month centrally act dopamine antagonist ( 6 month depot formulation ) , e.g. , antipsychotic neuroleptic , metoclopramide , buspirone , amoxapine . 4 . Neurosurgical operation Parkinson 's disease . 5 . Atypical parkinsonism secondary parkinsonism variant . 6 . Diagnosis cancer evidence continue disease within 5 year . 7 . Clinically significant illness organ system ( e.g. , ALT AST &gt; 1.5 time upper limit normal ) . 8 . MiniMental Status Examination score 25 less . 9 . History drug alcohol abuse dependence within 2 year . 10 . History psychotic illness seizure . 11 . Clinically relevant depression disorder . 12 . History neuroleptic malignant syndrome . 13 . Pregnancy lactation . Women child bear potential must use reliable method contraception .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Parkinson 's disease</keyword>
	<keyword>Levodopa</keyword>
	<keyword>End dose wear</keyword>
	<keyword>OFF time</keyword>
</DOC>